Campus of the University of Notre Dame

Jason Fournier has Joined Evercore as a Senior Managing Director in its Equity Capital Markets Practice

Retrieved on: 
Tuesday, July 19, 2022

Evercore (NYSE: EVR) announced today that Jason Fournier has joined the Firms Investment Banking business as a Senior Managing Director in its Equity Capital Markets (ECM) practice.

Key Points: 
  • Evercore (NYSE: EVR) announced today that Jason Fournier has joined the Firms Investment Banking business as a Senior Managing Director in its Equity Capital Markets (ECM) practice.
  • He is based in Menlo Park, CA and will lead and expand Evercore's Consumer & Retail ECM business.
  • Mr. Fournier joins from JPMorgan, where he previously led the Consumer & Retail ECM practice, and served in senior roles in Technology ECM, Equity Private Placements and Technology & Disruptive Consumer Commercial Banking.
  • Over his twenty-year career, he has focused on structuring and marketing IPOs, follow-ons, convertibles and private placements, working with emerging high-growth companies as well as well-established incumbents.

Johnny Ek, former GenMark CFO, Joins Specific Diagnostics as Chief Financial Officer

Retrieved on: 
Wednesday, August 18, 2021

MOUNTAIN VIEW, Calif., Aug. 18, 2021 /PRNewswire-PRWeb/ --Specific Diagnostics today announced the appointment of Johnny Ek as its Chief Financial Officer.

Key Points: 
  • MOUNTAIN VIEW, Calif., Aug. 18, 2021 /PRNewswire-PRWeb/ --Specific Diagnostics today announced the appointment of Johnny Ek as its Chief Financial Officer.
  • Mr. Ek had served since 2019 as the Chief Financial Officer of public company GenMark, overseeing its rapid growth to $200M in annual sales, and the process that led to its purchase by Roche Diagnostics for $1.8B in Q2 of this year.
  • Prior to joining GenMark, Mr. Ek was Vice President and International Controller at Affymetrix and Corporate Controller at eBioscience prior to its sale to Affy.
  • "Johnny brings the perfect set of skills and experience to Specific at this dynamic time in our commercial growth," said Dr. Paul A. Rhodes, Specific's CEO.